TheEdgeResearch
Home / Stocks / TELIF

Telescope Innovations Corp. (TELIF)

OTC Healthcare Biotechnology
$0.30 ▼ -4.51%
Market Cap
$24.2M
Sector
Healthcare
Industry
Biotechnology
Beta
1.33
52-Wk Range
0.21-0.76928
CEO
Henry Dubina
Country
CA
Currency
USD

Telescope Innovations Corp. operates in the Biotechnology industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.30, down 4.51% on the session, giving a market capitalisation of $24.2M. On trailing twelve-month figures it carries a trailing P/E of -7.42, a net margin of -56.0%. Its beta of 1.33 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-7.42
Price / Sales
4.65
Price / Book
10.01
EV / EBITDA
-8.88
Gross margin
2.2%
Operating margin
-70.6%
Net margin
-56.0%
Return on equity
Debt / equity
0.80
Current ratio
2.59
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
5
IPO date
2022-05-24
Headquarters
Vancouver, BC, CA
About Telescope Innovations Corp.

Telescope Innovations Corp. is a chemical technology firm dedicated to creating synthetic methods for producing pharmaceutical compounds. These compounds are specifically developed for use in treating mental health conditions. The company's main operational base is located in Vancouver, Canada.

Comparable companies

Telescope Innovations Corp. is most often compared with the following Healthcare names:

ACMSYCLCSGLABFHSITFMYCOFPPCBQPTFFSRBCFSYGGFZHCLF
More research on TELIF
TELIF technical analysis TELIF TheEdge Score Compare against peers
Open full interactive analysis & DCF →